Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Yi Chen

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Annals of Hepatology|May 19, 2026
Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradicationYen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, et al.
Clinical and Molecular Hepatology|March 26, 2024
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patientsMan-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, et al.
Cancers|November 13, 2021
The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular CarcinomaPo-Yueh Chen, Tsung-Jung Tsai, Hsin-Yi Yang, et al.
Journal of Gastroenterology and Hepatology|July 5, 2022
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanChih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, et al.
Alimentary Pharmacology & Therapeutics|October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 19, 2013
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapseChuan-Mo Lee, Chi-Yi Chen, Rong-Nan Chien, et al.
Clinical and Molecular Hepatology|October 17, 2024
Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trialYao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Journal of Hepatology|July 7, 2024
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHBWon Young Tak, Wan-Lobg Chuang, Chi-Yi Chen, et al.
The Kaohsiung Journal of Medical Sciences|July 14, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver DiseaseJee-Fu Huang, Chi-Yi Chen, Ming-Jong Bair, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Annals of Hepatology|May 19, 2026
Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradicationYen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, et al.
Clinical and Molecular Hepatology|March 26, 2024
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patientsMan-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, et al.
Cancers|November 13, 2021
The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular CarcinomaPo-Yueh Chen, Tsung-Jung Tsai, Hsin-Yi Yang, et al.
Journal of Gastroenterology and Hepatology|July 5, 2022
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanChih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, et al.
Alimentary Pharmacology & Therapeutics|October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 19, 2013
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapseChuan-Mo Lee, Chi-Yi Chen, Rong-Nan Chien, et al.
Clinical and Molecular Hepatology|October 17, 2024
Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trialYao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Journal of Hepatology|July 7, 2024
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHBWon Young Tak, Wan-Lobg Chuang, Chi-Yi Chen, et al.
The Kaohsiung Journal of Medical Sciences|July 14, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver DiseaseJee-Fu Huang, Chi-Yi Chen, Ming-Jong Bair, et al.
Pageof 14